These results are consistent with our previous work, showing that per se NAPRT silencing or inhibition do strongly sensitize NAPRT-expressing cancer cells (such as OVCAR-5, OVCAR-8, as well as other cell lines) to NAMPT inhibitors but by themselves have minor anti-proliferative activity [23]. The gene discussed is NAPRT; the disease is cancer.